Anticoagulant Sodium Citrate is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Csl Plasma Inc.. The primary component is Trisodium Citrate Dihydrate.
| Product ID | 81839-782_cbd2041d-cb3f-450c-af4b-3494c2b30b86 |
| NDC | 81839-782 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Anticoagulant Sodium Citrate |
| Generic Name | Trisodium Citrate Dihydrate |
| Dosage Form | Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-07-01 |
| Marketing Category | ANDA / |
| Application Number | BA125750 |
| Labeler Name | CSL Plasma Inc. |
| Substance Name | TRISODIUM CITRATE DIHYDRATE |
| Active Ingredient Strength | 40 mg/mL |
| Pharm Classes | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-07-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 62646-798 | Anticoagulant Sodium Citrate | Sodium Citrate |
| 76297-006 | Anticoagulant Sodium Citrate | Trisodium Citrate Dihydrate |
| 81839-782 | Anticoagulant Sodium Citrate | Trisodium Citrate Dihydrate |
| 57826-420 | Haemonetics Anticoagulant Sodium Citrate | TRISODIUM CITRATE DIHYDRATE |
| 14537-881 | Sodium Citrate 4% w/v Anticoagulant | TRISODIUM CITRATE DIHYDRATE |
| 14537-883 | Sodium Citrate w/v Anticoagulant | TRISODIUM CITRATE DIHYDRATE |
| 23731-6030 | triCitrasol | Trisodium Citrate dihydrate |